Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol as Adjunct to Stimulants in ADHD
NCT04386811Phase 1Terminated
- Sponsor
- Yale University
- Start
- Aug 2020
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Calcitriol + Stimulant with Placebo + Stimulant (2 arms). Primary endpoints: Enhanced positive neurocognitive effects on the CPT-IP up to 5 hours, Enhanced positive neurocognitive effects on the Spatial working memory task up to 5 hours and 1 more. Started Aug 2020; status: terminated.
02
Drugs
calcitriol
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04386811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04386811.